These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24585328)

  • 21. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
    Campion P
    Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of copper and ketamine in major depressive disorder - an update.
    Słupski J; Słupska A; Szałach ŁP; Włodarczyk A; Górska N; Szarmach J; Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Wiglusz MS; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):520-523. PubMed ID: 31488784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Speed of response to electroconvulsive therapy compared with ketamine.
    Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
    Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
    Yang JJ; Wang N; Yang C; Shi JY; Yu HY; Hashimoto K
    Biol Psychiatry; 2015 Feb; 77(3):e19-e20. PubMed ID: 25104172
    [No Abstract]   [Full Text] [Related]  

  • 25. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
    Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
    Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
    Murrough JW; Collins KA; Fields J; DeWilde KE; Phillips ML; Mathew SJ; Wong E; Tang CY; Charney DS; Iosifescu DV
    Transl Psychiatry; 2015 Feb; 5(2):e509. PubMed ID: 25689570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
    Owen RT
    Drugs Today (Barc); 2012 Jul; 48(7):469-78. PubMed ID: 22844658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ketamine for treatment of depression?].
    Vinberg M
    Ugeskr Laeger; 2013 Sep; 175(37):2089. PubMed ID: 24011202
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?
    Mansuri Z; Shah B; Yadav G; Kamil SH; Kainth T; Srinivas S; Patel H; Reddy A; Bachu A
    Prim Care Companion CNS Disord; 2024 Feb; 26(1):. PubMed ID: 38382071
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
    Rotroff DM; Corum DG; Motsinger-Reif A; Fiehn O; Bottrel N; Drevets WC; Singh J; Salvadore G; Kaddurah-Daouk R
    Transl Psychiatry; 2016 Sep; 6(9):e894. PubMed ID: 27648916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketamine-induced affective switch in a patient with treatment-resistant depression.
    Banwari G; Desai P; Patidar P
    Indian J Pharmacol; 2015; 47(4):454-5. PubMed ID: 26288483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Riluzole likely lacks antidepressant efficacy in ketamine non-responders.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():197-9. PubMed ID: 25139008
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral racemic ketamine for common clinical contexts in patients with major depressive disorder: An important intervention that treatment guidelines may never include.
    Andrade C
    Bipolar Disord; 2022 Mar; 24(2):113-114. PubMed ID: 34816542
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.
    Paul R; Schaaff N; Padberg F; Möller HJ; Frodl T
    World J Biol Psychiatry; 2009; 10(3):241-4. PubMed ID: 19224412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
    Kantrowitz JT; Halberstam B; Gangwisch J
    J Clin Psychiatry; 2015 Jun; 76(6):737-8. PubMed ID: 26132675
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression.
    Kallmünzer B; Volbers B; Karthaus A; Tektas OY; Kornhuber J; Müller HH
    J Neural Transm (Vienna); 2016 May; 123(5):549-52. PubMed ID: 26721476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule.
    Lauterbach EC
    Psychopharmacol Bull; 2016 Aug; 46(2):53-58. PubMed ID: 27738380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated dosing with oral racemic ketamine as a successful rescue intervention for coping with life events in recurrent major depressive disorder.
    Menon V; Kale A; Balasubramanian I; Andrade C
    Asian J Psychiatr; 2024 Apr; 94():103973. PubMed ID: 38402733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.